BioRender 图标

Ciliated epithelial cell 2 (damaged)

Ciliated epithelial cell 2 (damaged) - Editable icon of Ciliated epithelial cell 2 (damaged)
[{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8ec/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8ec/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8ed/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8ed/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8ee/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8ee/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8ef/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8ef/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f0/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f0/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f1/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f1/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f2/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f2/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f3/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f3/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f4/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f4/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f5/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f5/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f6/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f6/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f7/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f7/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f8/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f8/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8f9/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8f9/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8fa/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8fa/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8fb/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8fb/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8fc/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8fc/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8fd/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8fd/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8fe/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8fe/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b8ff/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b8ff/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b900/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b900/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b901/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b901/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b902/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b902/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b903/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b903/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b904/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b904/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b905/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b905/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b906/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b906/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b907/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b907/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b908/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b908/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b909/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b909/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b90a/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b90a/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b90b/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b90b/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b90c/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b90c/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b90d/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b90d/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b90e/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b90e/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b90f/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b90f/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b910/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b910/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b911/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b911/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b912/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b912/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b913/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b913/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b914/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b914/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b915/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b915/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b916/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b916/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b917/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b917/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b918/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b918/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b919/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b919/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b91a/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b91a/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b91b/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b91b/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b91c/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b91c/5d1e642e09f8320400b7f3cf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df469aed9462577e08b91d/5d1e642e09f8320400b7f3cf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df469aed9462577e08b91d/5d1e642e09f8320400b7f3cf.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
epithelium,columnar,epithelia,cilia,ciliated,damage,atrophy,pseudostratified epithelium,pseudostratified epithelial cell ciliated
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Ciliated epithelial cell 2 (damaged) icon JPEG

Ciliated epithelial cell 2 (damaged) icon PNG

Ciliated epithelial cell 2 (damaged) icon SVG

Ciliated epithelial cell 2 (damaged) icon GIF

BioRender 图标常见问题解答

How are scientists using the Ciliated epithelial cell 2 (damaged) icon in their work?

BioRender users often use the Ciliated epithelial cell 2 (damaged) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Ciliated epithelial cell 2 (damaged) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Ciliated epithelial cell 2 (damaged) icon customizable in BioRender?

Most icons in BioRender, including the Ciliated epithelial cell 2 (damaged) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Ciliated epithelial cell 2 (damaged) icon for publication or presentations?

Yes, figures containing the Ciliated epithelial cell 2 (damaged) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Ciliated epithelial cell 2 (damaged) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Ciliated epithelial cell 2 (damaged) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Ciliated epithelial cell 2 (damaged) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon